Lao People's Democratic Republic vs Mali: Hypertension effective treatment coverage (controlled hypertension)
Lao People's Democratic Republic
14.2%
in 2019
Mali
14.5%
in 2019
Lao People's Democratic Republic rank
119th
Mali rank
118th
Hypertension effective treatment coverage (controlled hypertension) over time
- Lao People's Democratic Republic
- Mali
How they compare
Mali currently reports 14.5% against 14.2% in Lao People's Democratic Republic, a difference of 0.3%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Lao People's Democratic Republic ahead.
Lao People's Democratic Republic ranks 119th and Mali ranks 118th of 193 countries.
Lao People's Democratic Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | Mali | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 3.8% | 3.1% | 0.7% | Lao People's Democratic Republic |
| 2000s | 7.3% | 5.6% | 1.7% | Lao People's Democratic Republic |
| 2010s | 12.3% | 11.1% | 1.2% | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Lao People's Democratic Republic or Mali?
- Mali, at 14.5% against 14.2% in Lao People's Democratic Republic as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Lao People's Democratic Republic and Mali?
- 0.3%, with Mali ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Mali?
- 30 years are reported by both, from 1990 to 2019.
- How do Lao People's Democratic Republic and Mali rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Lao People's Democratic Republic ranks 119th and Mali ranks 118th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.